Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
Effect of virtual reality-based balance training in multiple sclerosis.
Cognitive assessment in MS.
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: treatment with rituximab.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
Developing a community multiple sclerosis nursing service.
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis (OLTERMS)
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
Occupational Exposure and Risk of Central Nervous System Demyelination.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions.
Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Effect of fingolimod (FTY720) on cerebral blood flow, platelet function, and macular thickness in healthy volunteers.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Immunosuppressive monoclonal antibodies: current and next generation.
Origin and differentiation of microglia.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Evidence for a two-stage disability progression in multiple sclerosis.
Pages
« first
‹ previous
…
203
204
205
206
207
208
209
210
211
…
next ›
last »